Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > the more news we get

<< Previous

Bullboard Posts

Next >>

Comment by akv1955on Feb 17, 2021 12:44pm

107 Views

Post# 32585484

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:the more news we get

Ernesto I respectfully disagree with anything you say because your posts are nonsense.

The sp will eventually go higher but for now I believe there is room for it to go down below 50cents...

also, in your previous posts you said you wanted the sp to stay low so you can purchase more shares at a lower price... Im so confused from your comments lol

btw did any of you read my first posts? I talked about szls and it went up by 50% since that time....

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market